Gryphon Bio

Gryphon Bio, founded by experts in -omic research, is a clinical-stage bioconjugate company focused on precision medicine and biomarker discovery. The company's core mission is to develop and market novel blood tests for brain health by leveraging the discovery of temporal biomarkers—brain-specific molecules in the blood that change over time. These biomarkers can serve as indicators for various brain health conditions, positioning Gryphon Bio at the forefront of innovative diagnostics.

Notable affiliated individuals include the co-founders who have extensive backgrounds in -omic research. Gryphon Bio has attracted significant attention from investors interested in the burgeoning field of precision medicine. Key achievements include the identification of thousands of brain molecules that act as biomarkers, paving the way for groundbreaking diagnostic tools. The overall impact of Gryphon Bio lies in its potential to revolutionize brain health diagnostics, offering more precise and timely detection of neurological conditions.